Lymphadenectomy in stage-III serous cystadenocarcinoma of the ovary.
To elucidate the effects of lymphadenectomy on the prognosis for ovarian cancer. A retrospective study of 69 patients with stage-III serous cystadenocarcinoma was performed. Among the 69 patients, 36 were not treated by lymphadenectomy. Both pelvic and para-aortic lymphadenectomies were performed on 13 patients at the initial operation and on 11 at the second operation. The group (n = 13) treated by both pelvic and para-aortic lymphadenectomies at the initial operation had a disease-free survival rate that was significantly higher than the non-lymphadenectomy group (n = 36) or the group (n = 5) treated by pelvic or para-aortic lymphadenectomy alone (P < 0.04). These 54 patients were subjected to multivariate analysis for lymphadenectomy at the initial operation, and a significant correlation was found between disease-free survival rate and both pelvic and para-aortic lymphadenectomies (P < 0.05). These results suggest that systematic lymphadenectomy can reduce the rate of recurrence.